The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma.
about
A systematic review of the efficacy and safety experience reported for sorafenib in advanced renal cell carcinoma (RCC) in the post-approval setting.Metastatic renal cell carcinoma: how to make the best sequencing decision after withdrawal for intolerance to a tyrosine kinase inhibitor.Patient approach in advanced/metastatic renal cell carcinoma: focus on the elderly population and treatment-related toxicity.Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma.Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma.Association of liver cirrhosis severity with type 2 diabetes mellitus in hepatocellular carcinoma.
P2860
The effect of sorafenib treatment on the diabetic status of patients with renal cell or hepatocellular carcinoma.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@en
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@nl
type
label
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@en
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@nl
prefLabel
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@en
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
The effect of sorafenib treatm ...... l or hepatocellular carcinoma.
@en
P2093
Chiara Paglino
Ilaria Imarisio
Luigi Magnani
Riccardo Caccialanza
P2860
P304
P356
10.2217/FON.12.74
P407
P577
2012-08-01T00:00:00Z